MEREO BIOPHARMA GROUP PLC (MREO) Net income 2022–2025
MEREO BIOPHARMA GROUP PLC (MREO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$41.9MFY2025 · since FY2022: -$42.2M → -$41.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$41.9M | +3.2% |
| FY2024 | -$43.3M | -46.8% |
| FY2023 | -$29.5M | +30.2% |
| FY2022 | -$42.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MREO financial trends
MREO RevenueMREO Net marginMREO Gross profitMREO Gross marginMREO Operating incomeMREO Operating marginMREO Operating cash flowMREO Free cash flowMREO Capital expendituresMREO Return on equityMREO Stock buybacksMREO Dividends paidMREO Total assetsMREO Total liabilitiesMREO Shareholders’ equityMREO overview →